Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly ibandronate in women with rheumatoid arthritis and reduced bone mineral density on long-term glucocorticoids
KCT0000148Phase 4Recruiting
- Sponsor
- Korea Health Industry Development Institute
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ibandronate in rheumatoid arthritis (RA), osteoporosis, low bone mineral density, sponsored by Korea Health Industry Development Institute. Started Apr 2010; status: recruiting.
02
Drugs
ibandronate
03
Conditions
rheumatoid arthritis (RA)osteoporosislow bone mineral density
Beyond the preview
Go deeper on KCT0000148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000148.